A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria
about
sameAs
Tafenoquine for preventing relapse in people with Plasmodium vivax malariaTafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to dateG6PD deficiency: a classic example of pharmacogenetics with on-going clinical implicationsRationale for short course primaquine in Africa to interrupt malaria transmissionVisualisation and quantitative analysis of the rodent malaria liver stage by real time imagingHeterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regionsResistance to therapies for infection by Plasmodium vivaxRandomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjectsChemoprophylaxis of Tropical Infectious Diseases.Increased bioavailability of primaquine using poly(ethylene oxide) matrix extended-release tablets administered to beagle dogs.Expanding the Antimalarial Drug Arsenal-Now, But How?Antimalarial compounds in Phase II clinical development.Operational strategies to achieve and maintain malaria elimination.Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.Tafenoquine at therapeutic concentrations does not prolong Fridericia-corrected QT interval in healthy subjects.Design and Synthesis of Novel Hybrid Molecules against Malaria.Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice.Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta)Differential cytochrome P450 2D metabolism alters tafenoquine pharmacokinetics.Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjectsMalaria chemoprophylaxis: when should we use it and what are the options?Exposure-Response Analyses for Tafenoquine after Administration to Patients with Plasmodium vivax MalariaPrevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka.Atovaquone/proguanil for the prophylaxis and treatment of malaria.Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries.Tafenoquine: a promising new antimalarial agent.Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki.Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicityCytostatic versus cytocidal profiling of quinoline drug combinations via modified fixed-ratio isobologram analysis.A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infectionsEmerging drugs for malaria.Evolution from double to triple-antimalarial drug combinations.Fever after a stay in the tropics. Part 2: Common imported tropical diseases.Single dose treatment of malaria - current status and perspectives.The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.Pharmacodynamics of antimalarial chemotherapy.Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania majorEvaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency
P2860
Q24186356-745145A9-B864-4211-911D-2D65A728518DQ26741307-5072F919-1849-4915-964F-51CD9629C10CQ27005605-247886CC-0974-4108-A6CE-B925B72192E8Q27006552-C2B61E41-F4FB-4E52-A66A-631D8C591E77Q27335248-37D24EB2-80B5-435B-A632-0E26A6891D2AQ28559557-043480C4-635E-4280-9384-BC953BBFB148Q33481576-D812210B-6F2C-4FE5-AB14-8EF37B37A628Q33613720-F4DFC373-22BF-49B0-99ED-EA549544002EQ33664324-9307EC0D-58CA-41F8-A0E7-335581A39692Q33908425-B4F5C1F9-434E-4283-8D36-2B3DD8F7DC00Q33916111-BC1E37A9-DB60-40DD-AD32-445CF3F6589CQ34456807-3FE29BD1-06E1-4060-9279-E1256B2304D0Q34568019-679A832F-4182-46FA-9F09-F2D157FCDC2EQ34611917-A8A6295C-338F-4C72-842E-F0BACD9B0B6FQ34811224-BA217E9C-4F7A-4502-95D4-914DB77E92CFQ35103178-06978EA4-D3C3-404E-AF1C-E0C5FE493B0CQ35136121-CCDEF28F-17C9-45F6-B967-F524D972220FQ35181605-734C6B5C-4772-44E2-AE8C-364256E8405EQ35746028-327D96F2-A727-4B71-B2F4-66FF2666042CQ35912649-F142323D-13A1-4161-BD2F-B4DB023B4DACQ35917341-9FAC2A70-CE98-492F-B0EB-F536268FFEA8Q36075824-5C656C51-F3B4-45D3-B194-D3048E2404B0Q36267671-B2EFA778-C6B3-4600-B506-8C2F1969186FQ36322092-B413B8BD-0852-4E6A-BF66-DF30B362DB9AQ36324967-F75CC079-E44E-4C1A-A89B-1F64ABDB6B2CQ36802630-86417DD9-668D-45E4-B8CD-274614E0E8F8Q37052790-24E34374-C56D-4C5E-ABD7-D1A39B21FFCCQ37255996-2A80A7BE-12C9-4557-B4E5-4991C27AB6B0Q37418342-3A9A5CA6-402A-43DB-9B2E-1D2D2F5BC1D4Q37617688-66F353DA-577B-44E9-8AF7-973FB641BDF5Q37707806-07F95C07-6DEE-4466-A83F-BCF7239D7285Q38027179-A74D123B-B860-4624-8D59-8F8F5AEB2A65Q38303998-6A1D9C9C-69A6-400D-AF8B-75C3ACD735B6Q38916168-4D280650-604A-412B-BCEA-0B2D1B05DE50Q39253978-3B4C0E08-7EE3-4BBC-A96E-3DF307943DC4Q39351649-D2527BE2-280B-472F-ACF9-4283ECEFCD21Q41913336-FE9F0197-A38F-428D-B54B-F2E59C39D7A3Q41937695-D4D81B28-705F-4771-B31D-E54D3EDB9CACQ41984797-0344919A-803A-4E78-BE86-923A6988AC19Q42025500-D2FAB1F5-A454-45E2-9FCB-C011AA1C10A3
P2860
A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A new primaquine analogue, taf ...... Plasmodium falciparum malaria
@ast
A new primaquine analogue, taf ...... Plasmodium falciparum malaria
@en
A new primaquine analogue, taf ...... Plasmodium falciparum malaria
@nl
type
label
A new primaquine analogue, taf ...... Plasmodium falciparum malaria
@ast
A new primaquine analogue, taf ...... Plasmodium falciparum malaria
@en
A new primaquine analogue, taf ...... Plasmodium falciparum malaria
@nl
prefLabel
A new primaquine analogue, taf ...... Plasmodium falciparum malaria
@ast
A new primaquine analogue, taf ...... Plasmodium falciparum malaria
@en
A new primaquine analogue, taf ...... Plasmodium falciparum malaria
@nl
P2093
P2860
P3181
P356
P1476
A new primaquine analogue, taf ...... Plasmodium falciparum malaria
@en
P2093
D Braitman
G M Aleman
R Brueckner
P2860
P304
P3181
P356
10.1086/324081
P407
P577
2001-12-15T00:00:00Z